Ninerafaxstat

Overview of the antifungal drug Ninerafaxstat

Ninerafaxstat
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Ninerafaxstat is an investigational antifungal drug that has been studied for its potential use in treating various fungal infections. It is a member of the azole class of antifungal agents, which are known for their ability to inhibit the synthesis of ergosterol, a critical component of fungal cell membranes.

Mechanism of Action

Ninerafaxstat functions by inhibiting the enzyme lanosterol 14α-demethylase, which is involved in the biosynthesis of ergosterol. By disrupting this pathway, Ninerafaxstat compromises the integrity of the fungal cell membrane, leading to cell death. This mechanism is similar to other azole antifungals, but Ninerafaxstat has been designed to have a broader spectrum of activity and improved pharmacokinetic properties.

Pharmacokinetics

The pharmacokinetic profile of Ninerafaxstat includes its absorption, distribution, metabolism, and excretion. It is known to have good oral bioavailability, allowing it to be administered in oral form. The drug is metabolized primarily in the liver and excreted through the kidneys. Its half-life allows for once-daily dosing, which can improve patient compliance.

Clinical Trials

Ninerafaxstat has undergone several phases of clinical trials to evaluate its efficacy and safety. In early-phase trials, it demonstrated potent antifungal activity against a range of pathogenic fungi, including species of Candida and Aspergillus. Later-phase trials have focused on its use in patients with invasive fungal infections, particularly those who are immunocompromised.

Potential Uses

The primary indication for Ninerafaxstat is the treatment of invasive fungal infections, which are a significant cause of morbidity and mortality in immunocompromised patients, such as those undergoing chemotherapy or organ transplantation. It may also be used in the treatment of dermatophytosis and other superficial fungal infections.

Safety and Side Effects

As with other azole antifungals, Ninerafaxstat can cause side effects, including hepatotoxicity, gastrointestinal disturbances, and allergic reactions. Monitoring of liver function tests is recommended during treatment. Drug interactions are also a concern, as Ninerafaxstat can affect the metabolism of other medications metabolized by the cytochrome P450 system.

Related Pages

• Antifungal drug
• Azole
• Fungal infection
• Ergosterol